Trial intelligence / Profile preview

Propacetamol for Post-Cesarean Pain

NCT03878082Completed

Sponsor
Mackay Memorial Hospital
Start
Aug 2019
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of propacetamol in postoperative pain (3 arms), sponsored by Mackay Memorial Hospital. Primary endpoints: Change of pain assessed by NRS, Incidence of treatment-relate adverse events at 2 days and 1 more. Started Aug 2019; status: completed.

02

Drugs

propacetamol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03878082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03878082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call